ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DuPont Comes At Trian Swinging Once More

by Alexander H. Tullo
April 13, 2015 | APPEARED IN VOLUME 93, ISSUE 15

DuPont is once again lashing out at Trian Partners, the activist hedge fund that owns a 2.7% stake in DuPont and is trying to install four directors on DuPont’s board at its May 13 annual meeting. In a 51-page presentation on its position, the company advises shareholders against voting for all four Trian nominees. This is a departure from previous overtures where DuPont indicated it would be open to one Trian director. DuPont also estimates that Trian’s plans for the further breakup of DuPont, following the planned spin-off of its Chemours performance chemical unit, will cost $4 billion up front and $1 billion annually thereafter. In addition, DuPont’s board has sent a letter to shareholders touting its members’ qualifications to serve.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment